Aktis Oncology, Inc. is seeking a Senior Scientist, Radiopharmaceutical Development (MSAT) to own analytical methods and process controls for radiopharmaceutical products from late-stage development to commercialization.
You will lead method lifecycle management, support regulatory readiness, and collaborate across MSAT, Manufacturing, Quality, Regulatory Affairs, and external partners. The role requires deep expertise in analytical chemistry and radiochemistry, with experience in technology
#J-18808-Ljbffr
The Senior Radiopharmaceutical Development Scientist (MSAT) position in the Bio & Pharmacology & Health field is open for applications.
The advertised compensation is 122.000 - 149.000.
We aim to respond to suitable candidates as soon as possible.
Full responsibilities and requirements are described in the listing above.
Learn more about the Senior Radiopharmaceutical Development Scientist (MSAT) role in the description above.
We appreciate your interest in this position.
Join NCBioImpact and contribute to our ongoing work.